Mr. Nick Kuzyk reports

AGRA VENTURES ANNOUNCES RESULTS OF ITS ANNUAL GENERAL & SPECIAL MEETING

Agra Ventures Ltd. has provided voting results from its annual general and special meeting (AGSM) that was held today in Vancouver, B.C. A total of 43,331,793 common shares of the company were voted, representing 27.09 per cent of Agra's outstanding shares. Shareholders voted in favour of all applicable items of business set before the meeting, as shown in the attached table.

Nick Kuzyk, Fiona Fitzmaurice, Anthony Carnevale and Jonathan Hirsh were all re-elected to the board of directors at the AGSM.

Share consolidation

On May 30, 2023, and June 2, 2023, the company announced a proposed share consolidation, whereby Shareholders will receive one postconsolidation voting common share for up to 25 preconsolidation voting common shares held by them.

As the company has now received the requisite shareholder approval, it will be proceeding with the share consolidation. Details including the new Cusip/ISIN numbers and effective date will be announced in an upcoming news release.

About Agra Ventures Ltd.

Agra Ventures is a company focused on the cannabis industry. The company's wholly owned subsidiary, Farmako GmbH, is focused on becoming Europe's leading distributor of medical cannabis as well as its proprietary CBD (cannabidiol) and THC (tetrahydrocannabinol) test kits. Farmako currently has active product distribution operations in Germany and is fully licensed in the United Kingdom.

We seek Safe Harbor.